COVID-19 studies for: C19 studies:  HC QHC Q Vitamin DVitamin D IvermectinIVM LY-CoVLY REGN-COV2REGN RemdesivirRMD

Source   Share   Tweet
See all 143 studies
9/21
Safety
Early treatment study
Lofgren et al., medRxiv, doi:10.1101/2020.07.16.20155531 (Preprint) (not included in the study count)
Safety of Hydroxych loroquine among Outpatient Clinical Trial Participants for COVID-19
Analysis of 2,795 outpatients not showing significant safety concerns with HC Q. No deaths were related to HC Q. There was one serious event requiring hospitalization, identical to the frequency with placebo.
Source   Share   Tweet
See all 143 studies
Please send us corrections, updates, or comments.
Submit